ReviewClinical & experimental metastasis2025

Targeting metabolic and epigenetic reprogramming in metastatic fumarate hydratase-deficient renal cell carcinoma.

Nadja Kührer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.